pulmonary disease, chronic obstructive
Showing 51 - 75 of 876
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (QBW251, Placebo, COPD maintenance background therapy)
Completed
- Pulmonary Disease, Chronic Obstructive
- QBW251
- +2 more
-
Andalusia, Alabama
- +147 more
Jul 27, 2022
Smart Textile Sensor System for Health Monitoring
Recruiting
- Heart Disease Chronic
- +3 more
- Nanowear SimpleSense Wearable monitoring device
-
Atlanta, Georgia
- +2 more
Jul 22, 2022
Emphysema, Pulmonary Disease, Chronic Obstructive Trial in Porto Alegre, Heidelberg, Groningen (IAB System)
Recruiting
- Emphysema
- Pulmonary Disease, Chronic Obstructive
- IAB System
-
Porto Alegre, Brazil
- +2 more
Jul 15, 2022
(In)Voluntary Assessed Quadriceps Muscle Endurance in COPD
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Jun 16, 2022
Chronic Obstructive Pulmonary Disease (COPD) Participants
Recruiting
- Pulmonary Disease, Chronic Obstructive
- prospective observational cohort study
-
Hannover, Niedersachsen, GermanyGSK Investigational Site
Jun 20, 2022
Pulmonary Disease, Chronic Obstructive Trial in United States (Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy),
Completed
- Pulmonary Disease, Chronic Obstructive
- Stiolto Respimat
- +3 more
-
Mobile, Alabama
- +89 more
May 24, 2022
Early Intervention Efficacy in COPD
Completed
- Pulmonary Disease, Chronic Obstructive
-
Nara, JapanNara Medical University
May 24, 2022
Alzheimer, Late Onset, Stroke, Heart Failure Trial in Yilan (Health Education Manual, manual)
Completed
- Alzheimer Disease, Late Onset
- +7 more
- Health Education Manual
- manual
-
Yilan, TaiwanWen-Shiou Pan
Jun 6, 2022
Pulmonary Disease, Chronic Obstructive, Airway Disease, COPD Exacerbation Trial in San Francisco (Ozone exposure)
Active, not recruiting
- Pulmonary Disease, Chronic Obstructive
- +4 more
- Ozone exposure
-
San Francisco, California
- +2 more
Jun 6, 2022
Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- Placebo
- (no location specified)
May 26, 2022
Acute Exacerbation of COPD, Lung Diseases, Lung Diseases, Obstructive Trial in Hong Kong (The intervention (CRP-guided) group)
Not yet recruiting
- Acute Exacerbation of COPD
- +4 more
- The intervention (CRP-guided) group
-
Hong Kong, Hong KongQueen Mary Hospital
May 16, 2022
Pulmonary Disease, Chronic Obstructive Trial in Gastonia, Charleston (Self-management support)
Completed
- Pulmonary Disease, Chronic Obstructive
- Self-management support
-
Gastonia, North Carolina
- +1 more
May 16, 2022
Pulmonary Disease, Chronic Obstructive Trial in Pessac (quadricipital biopsy)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- quadricipital biopsy
-
Pessac, FranceHôpital Haut-Lévêque - CHU de Bordeaux
May 12, 2022
Pulmonary Disease, Chronic Obstructive, Pneumonia, Bacterial Trial in Ann Arbor (Bronchoscopy with bilateral bronchoalveolar
Completed
- Pulmonary Disease, Chronic Obstructive
- Pneumonia, Bacterial
- Bronchoscopy with bilateral bronchoalveolar lavages
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System
Apr 26, 2022
Pulmonary Disease, Chronic Obstructive Trial in Bad Reichenhall (Pulmonary Rehabilitation (usual care), Pulmonary Rehabilitation
Recruiting
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Rehabilitation (usual care)
- +2 more
-
Bad Reichenhall, GermanyKlinik Bad Reichenhall der Deutschen Rentenversicherung Bayern S
Apr 26, 2022
Pulmonary Disease, Chronic Obstructive Trial in Houston, Sugar Land, Webster (Balance Training, Breathing and Stretching
Active, not recruiting
- Pulmonary Disease, Chronic Obstructive
- Balance Training
- Breathing and Stretching Exercises
-
Houston, Texas
- +3 more
Apr 26, 2022
Pulmonary Disease, Chronic Obstructive Trial in Mus (mKOAH application)
Recruiting
- Pulmonary Disease, Chronic Obstructive
- mKOAH application
-
Muş, TurkeyNeşe ÖZDEMİR
Apr 14, 2022
Shared Adaptive, Multi-domain and Personalised Prediction and
Recruiting
- Pulmonary Disease, Chronic Obstructive
- +2 more
-
Enschede, NetherlandsMedisch Spectrum Twente
Apr 11, 2022
Wellinks Effect on COPD Hospital Readmissions
Not yet recruiting
- COPD
- +4 more
- Wellinks
- (no location specified)
Apr 14, 2022
Chronic Obstructive Pulmonary Disease and Eosinophilia Among
Completed
- Pulmonary Disease, Chronic Obstructive
- Minimal questionnaire
- +5 more
-
Londrina, Paraná, Brazil
- +3 more
Apr 11, 2022
South Korea Using Medical Records to Look at Different
Completed
- Pulmonary Disease, Chronic Obstructive
- Long-acting Muscarinic Antagonists (LAMA)
- Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
-
Seoul, Korea, Republic ofKonkuk University Medical Center
Feb 8, 2022
Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)
Completed
- Pulmonary Disease, Chronic Obstructive
- +4 more
- Lifestyle Intervention
-
Birmingham, Alabama
- +38 more
Mar 10, 2022
Acute Exacerbations of Chronic Obstructive Pulmonary Disease in
Active, not recruiting
- Pulmonary Disease, Chronic Obstructive
- Prospective observational cohort study
-
Fukuoka, Japan
- +12 more
Apr 4, 2022
Pulmonary Disease, Chronic Obstructive Trial in Chapel Hill, Winston-Salem (Albuterol eMDPI DS)
Recruiting
- Pulmonary Disease, Chronic Obstructive
- Albuterol eMDPI DS
-
Chapel Hill, North Carolina
- +1 more
Mar 30, 2022
Vahelva Respimat Regulatory Post-marketing Surveillance in
Completed
- Pulmonary Disease, Chronic Obstructive
- Vahelva® Respimat® (Tiotropium + Olodaterol fixed dose combination)
-
One Or Multiple Sites, Korea, Republic ofChonnam National University Hospital
Feb 28, 2022